CAREER DEVELOPMENT PANEL: TRAINING IN MEDICAL DECISION MAKING
Tuesday, October 25, 2016: 12:30 PM - 1:30 PM
Bayshore Ballroom Salon D, Lobby Level (Westin Bayshore Vancouver)
What should you consider when deciding to pursue graduate studies in medical decision-making? How should you choose a thesis topic and supervisor? What are your options for employment? What are the opportunities for bridging core MDM areas? In this year’s panel, SMDM experts will share their insights on training in medical decision-making across the entire career trajectory. The viewpoints of clinicians and non-clinicians will be represented. Panelists represent a range of core MDM areas.
Introductions from panelists will be followed by a question and answer session.
For more information please contact Ava John-Baptiste (ajohnbap@uwo.ca) or Shiyi Wang (shiyi.wang@yale.edu).
Panelists:
Stirling Bryan, PhD
University of British Columbia; Centre for Clinical Epidemiology & Evaluation
Director
Dr. Stirling Bryan is an economist with a career-long specialization in health care. His early career was spent in the UK, with appointments in London and Birmingham. In 2005, as a Harkness Fellow, he spent a year at Stanford University, moving to Canada in 2008. He is a Professor in UBC’s School of Population & Public Health, and Director of VCH’s Centre for Clinical Epidemiology & Evaluation. His research seeks to inform policy and practice – in the UK he had an extensive involvement with NICE, and in Canada he chairs CADTH’s Health Technology Expert Review Panel. Recently he was appointed as a Scientific Director, for Patient Oriented Research, in BC’s Academic Health Sciences Network.
Anne M. Stiggelbout, PhD
Leiden University Medical Center
Prof. Anne Stiggelbout is full professor of Medical Decision Making at the Leiden University Medical Center (LUMC), the Netherlands. Her research and teaching relate to shared decision making and risk communication, as well as to quality of life and outcome preference (utility) assessment. She has received grants from among others the Dutch Cancer Society and the Netherlands Organisations for Scientific Research (NWO) and Medical Research (ZonMw), on patient preference assessment, patient empowerment, and shared decision-making and risk communication, but also on quality of life measurement and clinimetrics. She teaches at the undergraduate, graduate and post-graduate levels, mostly in medicine. Prof. Stiggelbout is active in scientific advisory committees and boards in the area of medical decision making. She is Chair of the LUMC Medical Research Profile ‘Innovation in Health Strategy and Quality of Care’. She was President of the Society for Medical Decision Making (2011-2012), is member of the International Patient Decision Aids Standards Group, and member and co-founder of the Dutch Platform for Shared Decision Making.
R. Scott Braithwaite, MD, MSc, FACP
New York University School of Medicine
Professor
Department of Population Health
R. Scott Braithwaite, MD, MSc, FACP is a Professor of Medicine and Population Health, Director of the Division of Comparative Effectiveness and Decision Science (CEDS) at New York University School of Medicine and Past-President of the Society of Medical Decision Making. Dr. Braithwaite earned his MD from the State University of New York at Stonybrook and his MSc in Clinical Research from the University of Pittsburgh. Dr. Braithwaite also completed a fellowship in Clinical Decision Making at Tufts University and is a recipient of a prestigious Robert Wood Johnson Foundation Faculty Scholar award. He is an accomplished investigator in the field of decision science, quality and cost-effectiveness with an outstanding record of funding from the NIH and other extramural sources. As Chief of SOLVE, he is dedicated to advancing a program of rigorous, policy-relevant research to optimize quality and value in healthcare, incorporating methods of decision science, comparative effectiveness and cost effectiveness. In addition to his focus on improving care for chronic illness domestically, he also continues his important international work on HIV treatment strategies in developing countries.